Search research articles
Contact Us
Filters
Showing results (71-80 of 148) with videos related to
Page
of 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2019
Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update
Alok A Khorana, Shannon E McKernin, Jordan Berlin, et al.
Journal for Immunotherapy of Cancer
|
April 24, 2023
Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE)
Marwan Fakih, Wael Harb, Daruka Mahadevan, et al.
International Journal of Cancer
|
March 18, 2026
Dynamics of the association between circulating levels of miRNA and pancreatic cancer risk through the years prior to pancreatic cancer diagnosis
Hui Cai, Veronica Wendy Setiawan, Xingyi Guo, et al.
Targeted Oncology
|
September 11, 2019
First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody-Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer
Sung-Bae Kim, Funda Meric-Bernstam, Aparna Kalyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2014
A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors
Igor Puzanov, Colin R Lindsay, Laura Goff, et al.
Endocrine-Related Cancer
|
February 20, 2021
A clinical score for neuroendocrine tumor patients under consideration for Lu-177-DOTATATE therapy
Satya Das, Liping Du, Aimee Schad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2011
Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors
Patricia M Lorusso, Antonio Jimeno, Grace Dy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 1, 2005
A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas
Karen L Tedesco, Jordan Berlin, Mace Rothenberg, et al.
Cancer Medicine
|
February 28, 2014
Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer
Dana B Cardin, Laura Goff, Chung-I Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2005
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer
Karen L Tedesco, Jordan Berlin, Charles D Blanke, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 148) with videos related to
Sort By:
Page
of 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2019
Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update
Alok A Khorana, Shannon E McKernin, Jordan Berlin, et al.
Journal for Immunotherapy of Cancer
|
April 24, 2023
Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE)
Marwan Fakih, Wael Harb, Daruka Mahadevan, et al.
International Journal of Cancer
|
March 18, 2026
Dynamics of the association between circulating levels of miRNA and pancreatic cancer risk through the years prior to pancreatic cancer diagnosis
Hui Cai, Veronica Wendy Setiawan, Xingyi Guo, et al.
Targeted Oncology
|
September 11, 2019
First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody-Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer
Sung-Bae Kim, Funda Meric-Bernstam, Aparna Kalyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2014
A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors
Igor Puzanov, Colin R Lindsay, Laura Goff, et al.
Endocrine-Related Cancer
|
February 20, 2021
A clinical score for neuroendocrine tumor patients under consideration for Lu-177-DOTATATE therapy
Satya Das, Liping Du, Aimee Schad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2011
Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors
Patricia M Lorusso, Antonio Jimeno, Grace Dy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 1, 2005
A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas
Karen L Tedesco, Jordan Berlin, Mace Rothenberg, et al.
Cancer Medicine
|
February 28, 2014
Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer
Dana B Cardin, Laura Goff, Chung-I Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2005
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer
Karen L Tedesco, Jordan Berlin, Charles D Blanke, et al.
Page
of 15